Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
The World According to Monsanto the Rachel Carson Prize for her work on this project. The World According to Monsanto The World According to Monsanto is a 2008 film directed by Marie-Monique Robin. Originally released in French as "Le monde selon Monsanto", the film is based on Robin's three-year-long investigation into the corporate practices around the world of the United States multinational corporation, Monsanto. "The World According to Monsanto" is also the title of a book written by Robin. The film reports many controversies surrounding the use and promotion of genetically modified seeds, polychlorinated biphenyls (PCBs), Agent Orange, and bovine growth hormone. Cases in the